Sony Innovation Fund by Innovation Growth Ventures is a venture capital fund established in 2019 by Sony Corporation, Daiwa Capital Holdings Co., Ltd. and external limited partners.
Portfolio
3
companies
Divido
Divido provides a white-label platform for retail finance and point of sale payments.
Huma Therapeutics
Huma Therapeutics develops a modular digital health platform for virtual hospital care and decentralized clinical trials.
Token
Token provides an open banking payments platform connecting financial institutions across Europe.
Gen Tsuchikawa
CEO and Chief Investment Manager
The funding round was led by HSBC and ING to fuel international growth.
"The retail finance market is in a period of exponential growth, expected to hit $2.5 trillion next year. This provides banks with the opportunity to increase lending revenue, diversify their portfolio and neutralise the threat from new entrants."
The Series C financing was led by Leaps by Bayer and Hitachi Ventures to support international expansion and platform development.
"This is a pivotal moment in Huma’s development. We have exceptional partners and strategic investors who will support us in our mission to help people worldwide live longer and fuller lives. We’re already demonstrating how ‘hospital at home’ can transform healthcare, and how decentralized clinical trials can advance research in ways that weren’t imaginable even one year ago. Now we want to accelerate the pace of change and continue to innovate for better care and research worldwide."
The funding round was led by SBI Investment alongside Sony Innovation Fund by IGV and existing backers.
"The market’s appetite for open payments accelerated dramatically last year as more merchants and payment providers have tuned into the cost and efficiency gains that they offer,"
